Teewinot’s Irish subsidiary has been granted a fourth patent for a pharmaceutical cannabinoid manufacturing technique which it says saves both time and money.
Researchers studying chemical reactions in urine have created an adhesive gel for drug delivery applications that they say is cheaper and easier to make than hydrogel-based carriers.
The HIV drug API efaverinz could be made faster and more cheaply using continuous manufacturing according to the German team behind a new ‘assembly line’ production method.
CatScI says pharma demand for catalysis services is increasing due to a greater focus on economic sustainability as it inks a deal with SAFC for its chemical processes.
Northern Ireland-based Almac Group has launched its selectAZyme brand, which provides a wide range of enzymes such as reductases, hydrolases, nitrolases for manufacturing applications.
The Norwegian “green packaging” company, TimeTemp AS, intends to develop, produce and market freshness and quality indicators to the pharmaceutical industry that can be attached to cartons or pallets to determine the shelf life of a product.
Sweden’s Alfa Laval says ART PR49, its combined chemical reactor and heat transfer plate, improves the efficiency of chemical production and helps reduce energy costs.
US contract manufacturer Ash Stevens Inc has upgraded its active pharmaceutical ingredient (API) facility in Riverview, Michigan, with new equipment for parallel synthesis and calorimetry.
Japanese glass and chemical company Central Glass has found a swift
route into the contract manufacturing market for active
pharmaceutical ingredients (APIs) in Europe via the purchase of
Girindus' facility in Halle-Kuensebeck.
UK-based AM Technology has developed the Coflore Agitated Cell
Reactor (ACR) which it claims offers significant advantages over
traditional continuous stirred tank reactors.
Biotage has used the American Chemical Society (ACS) Spring 2008
meeting to introduce its new batch microwave synthesiser that
allows the full automation of batch sequencing resulting in time
savings for users.
In the world of chemistry the majority of reactions are well known
and have been around for a very long time producing similar
compounds. It is not very often that a completely new reaction
methodology comes along which can turn something...
A new high pressure microreactor has been developed that increases
chemical reaction rates compared to conventional alternatives -
potentially saving exploratory chemistry labs time and space.
New flow reactor heater allows high-speed, multi-step reactions in
front of your eyes allowing users to monitor progress and intervene
in case problems to avoid time and reagent waste.
Fine chemicals firm Degussa has decided to spin off its NCN
business in Bavaria into a new legal entity known as AlzChem
Trostberg, hoping a new name will lead to new opportunities.
BASF has announced it has managed to produce the chemical
intermediate N-ethyldiisoproylamine (EDIPA), also known as Huenig's
base, at a purity of at least 99.5 per cent, helping manufacturers
to stay clear from undesirable side...
Asynt have launched the first affordable 500ml parallel reactor on
the market with its latest addition to the DrySyn range, providing
a safe and flexible alternative to oil bath and mantles.
Researchers have developed a new catalyst process that offers
faster reaction rates, a substantially higher product yield and a
cleaner production process than is currently available in the
pharmaceutical and chemical industry.
Degussa have discovered a catalyst that improves the efficiency of
reductive carbonylation reactions and will provide greater access
to new active pharmaceutical ingredients (APIs).
The Pharmaceutical Fine Chemicals Business of Clariant took the
opportunity to review new developments at the CPhI Expo in Madrid,
Spain, making announcements on new investments in facilities in
Europe and the US as well as new business...
CEM Corp has announced the formation of a division within the
company that will be focused on developing systems for scaling up
reactions performed using microwave synthesis.
One of the biggest challenges in catalysed chemical reactions is to
remove and recycle the catalyst once the process is complete. A new
approach, using Teflon, could make recovery simpler and cut down on
the use of solvents, writes...
While the Drug Discovery Technology Europe show placed an emphasis
on issues surrounding drug research, companies serving the pharma
and biotech industries took the opportunity to showcase the latest
technologies that are set to prove...
Specialty chemicals company Degussa has developed an put in place
an automated workstation that should speed up process development
and scale-up projects for its clients.
Fine and specialty chemicals company Avecia is planning to spin out
part of its pharmaceutical technologies portfolio into a new
company to be called Reaxa. The move should complete before the end
of this quarter.
Clariant's pharmaceutical fine chemicals business announced a
series of upgrades to its manufacturing facilities around the
world, headed by a new push into contract manufacture of controlled
substances.
After a successful trial period, Syrris has supplied one of its
recently-launched AFRICA microreactor systems to Professor Steven
Ley at the Department of Chemistry at the University of Cambridge,
UK. His group will use the system...
German contract development and manufacturing company Girindus has
installed a microwave system at its plant in the US, reflecting a
growing trend in the sector to use microwaves to improve reaction
yields.
Scientists have reworked the mechanism of how enzymes work, forcing
the pharmaceutical industry to rethink its views on the design of
biological catalysts and new drugs.
Bayer has boosted its presence in the developing microtechnology
market with the acquisition of Ehrfeld Mikrotechnik, a specialist
in the manufacture of tiny reactors for chemical processes.
A new unit operating at Clariant Pharmaceuticals in Germany will
boost the company's activities in the emerging field of
microreactor technology for the production of pharmaceutical
intermediates and active pharmaceutical ingredients...
Switzerland's Lonza Group said yesterday that it will use a novel
process developed by US-based biocatalysis company Codexis for the
synthesis of a key chiral pharmaceutical compound used in one of
the world's major human...
Rudolf Hanko, formerly head of the fine chemicals business unit at
Bayer, has joined Degussa as head of the company's exclusive
synthesis business line, part of Degussa's Exclusive Synthesis
& Catalysts business unit.
UK-based chemistry specialist Syrris has developed a new
microreactor that, it claims, can speed up the optimisation of
process reactions used in the drug industry.
Sweden's Biotage has launched a system for carrying out microwave
synthesis reactions that for the first time is targeted at the
individual medicinal chemist.
Process chemists who want to test a number of reactions at
small-scale before ramping up to commercial production could
benefit from a new system, developed by Argonaut Technologies, that
can carry out four separate reactions in parallel.
A new company spun out from the University of Durham in the UK,
called LyraChem, has developed a new catalytic technology for the
pharmaceutical and chemical sectors that should reduce the amount
of wastage and contamination that...
The global market for nanocatalysts will amount to $3.7 billion in
2004 and is expected to reach $5.0 billion in 2009, according to
soon-to-be-released market research.
Two Dutch researchers have developed a method for managing batch
productions - widely used in the pharmaceutical industry - which
has the potential of improving yields and reducing the number of
lost batches.
A new machine from Ultrasonic Scientific promises to revolutionise
the analysis of chemical reactions by requiring only a tiny amount
of sample, an important consideration when testing expensive
biologic compounds.
Bayer Fine Chemicals has developed a new way to make chiral
epoxides that could shorten reaction times and reduce the amount of
expensive catalysts used in the process.
Kiadis of the Netherlands has acquired the entire issued share
capital and assets of Selact in a move that bolsters its
capabilities in chemical synthesis and contract research.
The completion of Degussa's reorganisation of its fine chemicals
activities into two separate business units heralds a raft of new
projects at the company.
